Animal models in influenza vaccine testing

被引:70
作者
van der Laan, Jan Willem [1 ]
Herberts, Carla [1 ]
Lambkin-Williams, Robert [2 ,3 ]
Boyers, Alison [2 ,3 ]
Mann, Alexander J. [2 ,3 ]
Oxford, John [2 ,3 ]
机构
[1] Natl Inst Publ Hlth & Environm, Ctr Biol Med & Med Technol, Sect Safety Med & Teratol, NL-3720 BA Bilthoven, Netherlands
[2] Barts & London Queen Marys Sch Med & Dent, Ctr Infect Dis, London, England
[3] Retroscreen Virol, London, England
关键词
animal model; disease end point; ferret; influenza vaccine; macaque; mouse; pandemic;
D O I
10.1586/14760584.7.6.783
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The threat of a pandemic outbreak of influenza A H5N1 and H2N2 has brought attention to the development of new vaccines. Regulatory authorities require companies to provide data proving the effectiveness of vaccines, which cannot, however, be based on real efficacy data in humans. A weight-of-evidence approach may be used, based on evidence of protection in an appropriate animal model and the satisfaction of the surrogate end points in the clinical situation. In this review, we will discuss various animal species that can be infected with influenza. The main animals used for testing vaccines destined for human use are laboratory mice and ferrets and, to a lesser extent, macaques. We will focus particularly on these species.
引用
收藏
页码:783 / 793
页数:11
相关论文
共 71 条
[1]  
Andrewes CH, 1941, BRIT J EXP PATHOL, V22, P91
[2]  
[Anonymous], 1920, REPORTS PUBLIC HLTH, V4
[3]   EVALUATION OF LIVE AND INACTIVATED INFLUENZA-A VIRUS-VACCINES IN A MOUSE MODEL [J].
ARMERDING, D ;
ROSSITER, H ;
GHAZZOULI, I ;
LIEHL, E .
JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (03) :320-330
[4]   Integrated molecular signature of disease: Analysis of influenza virus-infected macaques through functional genomics and proteomics [J].
Baas, T. ;
Baskin, C. R. ;
Diamond, D. L. ;
Garcia-Sastre, A. ;
Bielefeldt-Ohmann, H. ;
Tumpey, T. M. ;
Thomas, M. J. ;
Carter, V. S. ;
Teal, T. H. ;
Van Hoeven, N. ;
Proll, S. ;
Jacobs, J. M. ;
Caldwelll, Z. R. ;
Gritsenko, M. A. ;
Hukkanen, R. R. ;
Camp, D. G., II ;
Smith, R. D. ;
Katze, M. G. .
JOURNAL OF VIROLOGY, 2006, 80 (21) :10813-10828
[5]   Determination of levodopa and biogenic amines in urine samples using high-performance liquid chromatography [J].
Baranowska, Irena ;
Plonka, Joanna .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2008, 46 (01) :30-34
[6]   Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina) [J].
Baskin, CR ;
García-Sastre, A ;
Tumpey, TM ;
Bielefeldt-Ohmann, H ;
Carter, VS ;
Nistal-Villán, E ;
Katze, MG .
JOURNAL OF VIROLOGY, 2004, 78 (19) :10420-10432
[7]   Influenza virus host resistance model [J].
Burleson, Gary R. ;
Burleson, Florence G. .
METHODS, 2007, 41 (01) :31-37
[8]  
Burnet F. M., 1942, MONOGR WALTER AND ELIZA HALL INST RES PATH AND MED, V4, P1
[9]   Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential [J].
Desheva, J. A. ;
Lu, X. H. ;
Rekstin, A. R. ;
Rudenko, L. G. ;
Swayne, D. E. ;
Cox, N. J. ;
Katz, J. M. ;
Klimov, A. I. .
VACCINE, 2006, 24 (47-48) :6859-6866
[10]  
FENTON RJ, 1981, BRIT J EXP PATHOL, V62, P297